Catalyst Wire Dossier Catalyst Wire Dossier

ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%

albuterol sulfate · Ritedose Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%, covering 2025-03-12 to 2025-03-12. Get the full timeline:

Most recent: FDA Approved: ALBUTEROL SULFATE INHALATION SOLUTION, 0.5% — Original Application (Ritedose Pharmaceuticals, LLC)

See pricing